Analysts: Ads for BPH drugs don't help device makers

03/30/2008 | Pioneer Press (St. Paul, Minn.)

Television ads for drugs such as Flomax and Avodart that treat benign prostatic hyperplasia have resulted in either flat or reduced growth for device makers such as Medtronic, Urologix and American Medical Systems, analysts said. Effective drug advertising and the prevalence of hospital-based laser treatments appear to have altered the market for device treatments.

View Full Article in:

Pioneer Press (St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX